Journal of Cancer Clinical Trails (JCCT) and COVID-19 Pandemic

James A Radosevich^*
*Correspondence: James A Radosevich, Department of Oncology, Hospital of Speciality of Rabat University, Sao Paulo, Brazil, Email:

Editorial Note

Journal of Cancer Clinical Trials (JCCT), it is a exceptional journal that serves as a forum for high-impact research. The complete journal is about Cancer which is a group of diseases results in growth of abnormal cell with the ability to occupy or spread to other parts of the body. JCCT research studies carried out on human volunteers to test the benefit of a new drug or procedures. Generally, these studies are mainly conducted to prevent, detect or treat cancer. Building on the outstanding leadership of the previous Editors- in- Chief and its unique and valuable contribution to the field of cancer clinical research, the current transition in leadership provides the opportunity for new directions and goals to ensure the continued success of JCCT in the coming years.

The main aim and scope of JCCT is to publish genuine research on all types of cancer clinical trials, including breast cancer, lung cancer, ovarian cancer, liver cancer, bladder cancer, prostate cancer, blood cancer, colon cancer, cervical cancer, skin cancer, oesophagal cancer, kidney cancer, brain cancer, metastatic breast cancer, osteosarcoma, oncology, cancer clinical trials and ethical issues, glioblastoma, cancer clinical trials management, etc. The JCCT plays an key role in the digital advertising of the articles, research papers, etc. which helps the authors to increase the number of viewers effectively. Similarly, it also tries its level best to follow the ethics and publish the work with utmost quality. Social networking sites like Face book, Twitter, Linked In, it shares the latest information regarding the journal.

The COVID-19 pandemic is an on-going pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus. Initially it is identified in December 2019 in Wuhan, China. COVID-19 symptoms are highly variable, ranging from none to severe illness. Generally, the virus spreads through the air when people are close contact with each other. COVID-19 leaves an infected person as they breathe, cough and sneeze and it enters another person via their mouth, nose, or eyes and also it may spread via contaminated surfaces. This pandemic have resulted in global social and economic disruption, which includes the largest global recession since the Great Depression. Similarly, many educational institutions have been partially or fully closed. And Misinformation has circulated through social media and mass media. This pandemic has exposed the longstanding structural drivers of health inequities, such as precarious and adverse working conditions, growing economic disparities, and anti-democratic political processes and institutions. So, these important determinants of health have interlinked with class, ethnicity, gender, education level, and other factors during covid-19 to exacerbate existing social vulnerabilities in society.

The JCCT plays an key role in the digital advertising of the articles, research papers, etc. which helps the authors to increase the number of viewers productively. Similarly, it tries its level best to maintain the ethics and publish the work with utmost quality and also it values the contribution of the author and helps in generating excellent profile sites for them. I thank all the cancer specialist, oncology specialist and researchers who are fighting their life to treat the pandemic cancer diseases and all medical advisors, writers for making the experimental demonstration into a written document.

Therefore, I appreciate all the Editors and reviewers of the Journal who has stepped up and made the journal a success. And I hope this support will be continued by all of them and maintain the standard of the Journal.